Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada

Search

Controlled Drugs and Substances Act

Version of the schedule from 2003-12-11 to 2005-08-09:


SCHEDULE III(Sections 2 to 7, 29, 55 and 60)

  • 1 Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:

    • (1) amphetamine (a–methylbenzeneethanamine)

    • (2) methamphetamine (N,a–dimethylbenzeneethanamine)

    • (3) N–ethylamphetamine (N–ethyl–a–methylbenzeneethanamine)

    • (4) 4–methyl–2,5–dimethoxyamphetamine (STP) (2,5–dimethoxy–4,a–dimethylbenzeneethanamine)

    • (5) 3,4–methylenedioxyamphetamine (MDA) (a–methyl–1,3–benzodioxole–5–ethanamine)

    • (6) 2,5–dimethoxyamphetamine (2,5–dimethoxy–a–methylbenzeneethanamine)

    • (7) 4–methoxyamphetamine (4–methoxy–a–methylbenzeneethanamine)

    • (8) 2,4,5–trimethoxyamphetamine (2,4,5–trimethoxy–a–methylbenzeneethanamine)

    • (9) N–methyl–3,4–methylenedioxyamphetamine (N,a–dimethyl–1,3–benzodioxole–5–ethanamine)

    • (10) 4–ethoxy–2,5–dimethoxyamphetamine (4–ethoxy–2,5–dimethoxy–a–methylbenzeneethanamine)

    • (11) 5–methoxy–3,4–methylenedioxyamphetamine (7–methoxy–a–methyl–1,3–benzodioxole–5–ethanamine)

    • (12) N,N–dimethyl–3,4–methylenedioxyamphetamine (N,N, a–trimethyl–1,3–benzodioxole–5–ethanamine)

    • (13) N–ethyl–3,4–methylenedioxyamphetamine (N–ethyl–a–methyl–1,3–benzodioxole–5–ethanamine)

    • (14) 4–ethyl–2,5–dimethoxyamphetamine (DOET) (4–ethyl–2,5–dimethoxy–a–methylbenzeneethanamine)

    • (15) 4–bromo–2,5–dimethoxyamphetamine (4–bromo–2,5–dimethoxy–a–methylbenzeneethanamine)

    • (16) 4–chloro–2,5–dimethoxyamphetamine (4–chloro–2,5–dimethoxy–a–methylbenzeneethanamine)

    • (17) 4–ethoxyamphetamine (4–ethoxy–a–methylbenzeneethanamine)

    • (18) Benzphetamine (N–benzyl–N,a–dimethylbenzeneethanamine)

    • (19) N–Propyl–3,4–methylenedioxyamphetamine (a–methyl–N–propyl–1,3–benzodioxole–5–ethanamine)

    • (20) N–(2–Hydroxyethyl)–a–methylbenzeneethanamine

    • (21) N-hydroxy-3,4-methylenedioxyamphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)

    • (22) 3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzeneethanamine)

  • 2 Methylphenidate (a–phenyl–2–piperidineacetic acid methyl ester) and any salt thereof

  • 3 Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof

  • 4 Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof

  • 5 Lysergic acid diethylamide (LSD) (N,N–diethyllysergamide) and any salt thereof

  • 6 N,N–Diethyltryptamine (DET) (3–[(2–diethylamino) ethyl]indole) and any salt thereof

  • 7 N,N–Dimethyltryptamine (DMT) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof

  • 8 N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof

  • 9 Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof

  • 10 Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof

  • 11 Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof

  • 12 Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof

  • 13 N–(1–phenylcyclohexyl)ethylamine (PCE) and any salt thereof

  • 14 1–[1–(2–Thienyl) cyclohexyl]piperidine (TCP) and any salt thereof

  • 15 1–Phenyl–N–propylcyclohexanamine and any salt thereof

  • 16 Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof

  • 17 Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)

  • 18 4–Methylaminorex (4,5–dihydro–4–methyl–5–phenyl–2–oxazolamine) and any salt thereof

  • 19 Cathinone ((–)–a–aminopropiophenone) and any salt thereof

  • 20 Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof

  • 21 2–Methylamino–1–phenyl–1–propanone and any salt thereof

  • 22 1–[1–(Phenylmethyl)cyclohexyl]piperidine and any salt thereof

  • 23 1–[1–(4–Methylphenyl)cyclohexyl]piperidine and any salt thereof

  • 24 4–bromo–2,5–dimethoxybenzeneethanamine and any salt, isomer or salt of isomer thereof

  • 25 Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any salts or derivatives thereof

  • 26 4-hydroxybutanoic acid (GHB) and any salt thereof

  • 27 Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof

  • 28 Etryptamine (3-(2-aminobutyl)indole) and any salt thereof

  • 29 Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine) and any salt thereof

  • 30 Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof

  • 31 Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof

  • 32 Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof

  • 1996, c. 19, Sch. III
  • SOR/97-230, ss. 7 to 10
  • SOR/98-173, s. 1
  • SOR/2000-220, s. 1
  • SOR/2003-32, ss. 2, 3, 4(F), 5
  • SOR/2003-412

Date modified: